ICER assesses value of CAR T-cell therapiesMarch 27, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive Lymphomas
FDA approves nilotinib for kids with CMLMarch 23, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Health Canada approves SC rituximab for CLLMarch 23, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyAggressive Lymphomas
Ponatinib efficacy maintained despite dose reductionsMarch 23, 2018Leukemia, Myelodysplasia, TransplantationCML
FDA approves BV plus chemo for untreated cHLMarch 21, 2018Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas